Latest news with #ADHD
Economic Times
4 hours ago
- Business
- Economic Times
Cipla eyes entry into India's weight management market amid rising demand and global competition
Synopsis Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also strengthening its central nervous system portfolio through strategic in-licensing deals and acquisitions, particularly in ADHD and Parkinson's disease. The company is also focusing on innovation-led solutions to combat antimicrobial resistance and aims to be a global, patient-centric healthcare leader. Agencies Representative image Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra has Mumbai-based firm is also strengthening its presence in the central nervous system (CNS) therapeutic area, he stated in his address to shareholders in the company's Annual Report for 2024-25."Our efforts are rooted in understanding patient needs, reducing stigma, and delivering differentiated therapies for niche is emerging as a priority area for Cipla. With a clear strategic intent, we are preparing to enter the weight management segment in India, aiming to address the rising demand for effective obesity solutions," Vohra domestic drug firms are developing drugs for weight loss to capitalise on the growing market for obesity and diabetes drugmaker Eli Lilly & Co has already launched its anti-obesity drug Mounjaro in the country. Danish firm Novo Nordisk has also launched its anti-obesity drug Wegovy, indicated for both long-term chronic weight management and reduction in risk of major adverse cardiovascular the CNS segment, Cipla has successfully in-licensed Sanofi's India CNS product range, including Frisium, a leading brand in the anti-epileptic category, Vohra informed shareholders."Building on this momentum, we aim to pursue similar in-licensing deals or acquisitions in niche indications of attention deficit hyperactivity disorder (ADHD) and Parkinson's disease," he company is equally committed to addressing the global crisis of antimicrobial resistance (AMR), he added."Our AMR portfolio is evolving from volume-based to innovation-led, with four novel products in development," Vohra noted that the company's ambition is to be a global, innovation-led, patient-centric healthcare company that creates long-term value through science, empathy, and sustainability."We will continue to invest in big brands, strategic alliances, digital infrastructure, and next-generation therapies, while remaining rooted in our founding values of care and compassion," Vohra stated. Cipla's consolidated revenue stood at Rs 27,548 crore in FY25. Its consolidated net profit rose to Rs 5,272 crore during the period.
Daily Mail
6 hours ago
- Health
- Daily Mail
The Special Educational Needs scandal: How ‘sharp-elbowed' parents who insist their badly behaved children suffer from ADHD are ruining the lives of youngsters with real special needs
Eight-year-old Bryn was a disruptive pupil. He roamed the classroom as if he owned it, asked silly questions and, given the chance, was prone to demolishing things. When his case came to the desk of child psychiatrist Dr Mike Shooter, he faced intense pressure from Bryn's middle-class, professional parents to produce a diagnosis of ADHD (attention-deficit hyperactivity disorder).
Mint
6 hours ago
- Business
- Mint
Cipla to enter into weight management segment in India, says MD Umang Vohra
Drugmaker Cipla's MD and global CEO Umang Vohra has announced that the company is planning to enter into the weight management segment in India. The pharma major is also strengthening its presence in the central nervous system (CNS) therapeutic area, Vohra stated in the company's Annual Report for 2024-25. "Our efforts are rooted in understanding patient needs, reducing stigma, and delivering differentiated therapies for niche is emerging as a priority area for Cipla. With a clear strategic intent, we are preparing to enter the weight management segment in India, aiming to address the rising demand for effective obesity solutions," Vohra said. In the CNS segment, the Mumbai-based company has successfully in-licensed Sanofi India's CNS product range, including Frisium, a leading brand in the anti-epileptic category, he added. He also said: "Building on this momentum, we aim to pursue similar in-licensing deals or acquisitions in niche indications of attention deficit hyperactivity disorder (ADHD) and Parkinson's disease." Several domestic pharma companies are developing drugs for weight loss to capitalise on the growing market for obesity and diabetes management. American drugmaker Eli Lilly & Co has already launched its anti-obesity drug Mounjaro in India. Denmark's Novo Nordisk has also launched its anti-obesity drug Wegovy, indicated for both long-term chronic weight management and reduction in risk of major adverse cardiovascular events. For fiscal year 2025, Cipla reported consolidated revenue of ₹ 27,548 crore. Its consolidated net profit increased to ₹ 5,272 crore. Umang Vohra further said the company is equally committed to addressing the global crisis of anti-microbial resistance (AMR). "Our AMR portfolio is evolving from volume-based to innovation-led, with four novel products in development," he said. "We will continue to invest in big brands, strategic alliances, digital infrastructure, and next-generation therapies, while remaining rooted in our founding values of care and compassion," he added.
BBC News
10 hours ago
- Entertainment
- BBC News
Neurodiversity festival in Exeter born from 'passion project'
A mother with autism and ADHD has worked with an art venue to put together a festival celebrating neurodiversity in Way-Evans, who was diagnosed with the conditions two years ago at 38, said the Kaleidoscopic Minds Festival of Neurodiversity in Exeter was a "passion project" for event is on from 11:00 to 16:00 BST at Exeter said it featured workshops, a family disco and various activities for neurodivergent people and families. Ms Way-Evans, who has two neurodivergent children, said she "wanted to create an event which is for families like mine... to feel welcome and understood and just to kind of relax and have a nice day"."The hope is that people will take something from it, whether it's a feeling of connection, maybe some tools and strategies, information," she "pay what you can" event would see local neurodivergent charities on site, such as Dimensions for Autism, to offer resources to Way-Evans said people could "book a free ticket if you need to, otherwise it's £5 or £10"."The lovely team at the Phoenix have kind of allowed me to create it and they've helped me make it happen," she said"It's for all ages and everyone's welcome." There are movement and writing workshops, art and printing workshops aimed specifically for people with disabilities, guidance on regulation techniques and a family rave. There will also be ear defenders available for those who need them, as well as two regulation areas, a play room and a sensory Way-Evans said: "I've done as much as I can to design it specifically for neurodivergent people based on my experience... and I've tried to think of everything but if there's anything I've missed I would really love to know."I have put a lot of effort into it, and it's been a bit of a passion project for me, it's obviously very close to my heart."
Yahoo
14 hours ago
- Entertainment
- Yahoo
Emily Deschanel Recalls Having Panic Attacks During Season 1 Of ‘Bones' & Feeling 'Shame' After Being Reprimanded For Being 'Unprepared'
Emily Deschanel recalled struggling emotionally and professionally while filming the first season of Fox's Bones, to the point where she got a talking-to about her lack of preparedness. In a recent episode of podcast Fail Better with host David Duchovny, who once directed an episode of the police procedural, Deschanel opened up about the pain point and how her diagnosis of ADHD and dyslexia as a child affected her career later on. More from Deadline 2025 Premiere Dates For New & Returning Series On Broadcast, Cable & Streaming Annie Potts Joins Fox Medical Comedy 'Best Medicine' News UK Expands Original IP Ambitions With 14 Projects In Development Based On Its Archive 'We were working insane hours, longer than just a normal series,' Deschanel began. 'You're working 14- to 16-hour days, and then I had to memorize the lines. So I'd be staying up late night memorizing lines. I would joke that I would go home and just cry in a bathtub every night because I was just so overwhelmed.' She continued, 'I'd come to set and I would be trying to remember the lines that — I got no sleep and trying to remember the lines that I had memorized the night before and then I had them in my head and couldn't remember them.' Deschanel said moments like that would result in 'tunnel vision' and feel 'exposing' in front of crew members and other peers who were dependent on her performance to get through shoot days. 'I didn't know I was having panic attacks, but I was basically having panic attacks at the time,' she recalled. And when Deschanel was once 30 minutes late to work because of an accident on her commute, series creator Hart Hanson was forced to deliver a harsh message from his superiors. 'Hart knocked on my trailer door, which was not a usual thing, he wasn't knocking on my door often,' she remembered, chuckling ruefully. 'He took me aside and said, 'The studio has concerns about your work.' They said that I was late and unprepared. And that to me — I get emotional just thinking about it now because it was probably shame [that I was feeling].' Continuing tearfully, she said, 'I mean, I was a wreck … I took it so hard, and I was such a fragile person at the time. I got hardened up doing that show for so long. I was not sleeping, I was so stressed out. I was already, I'm an emotional person, so I was just beside myself.' However, Deschanel said the moment served as a wake-up call of sorts in that she was never late to set again. The following day Bones was also picked up for more episodes, with the eventual tally for the 12-season series comprising 246 episodes from 2005 through 2017. Deschanel added that she was able to get through the long-running series after Hanson offered her practical 'support,' such as by getting someone to run lines with her and a bigger trailer to match costar David Boreanaz's. 'Hart helped me find ways to be better, get my job done in terms of learning my lines and remembering them, and a lot of it was having downtime or having some scene that I'm not in, et cetera. He's just a good one. We were so lucky,' she concluded. Loosely based on the life and novels of forensic anthropologist Kathy Reichs, a producer on the show, each episode of Bones unpacks an FBI case file surrounding the mystery of human remains, as well as the personal lives of its central characters. The show garnered two Emmy nods throughout its run. Best of Deadline 'The Buccaneers' Season 2 Release Schedule: When Do New Episodes Come Out? 'The Buccaneers' Season 2 Soundtrack: From Griff To Sabrina Carpenter 2025 TV Series Renewals: Photo Gallery
